LBWCX
Price
$21.25
Change
+$0.12 (+0.57%)
Updated
Jul 3 closing price
Net Assets
93.34M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LBWCX vs VIVAX

Header iconLBWCX vs VIVAX Comparison
Open Charts LBWCX vs VIVAXBanner chart's image
BrandywineGLOBAL Div US Large Value C
Price$21.25
Change+$0.12 (+0.57%)
VolumeN/A
Net Assets93.34M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LBWCX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LBWCX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBWCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. LBWCX (93.3M). VIVAX pays higher dividends than LBWCX: VIVAX (2.06) vs LBWCX (0.69). LBWCX was incepted earlier than VIVAX: LBWCX (15 years) vs VIVAX (33 years). LBWCX (1.91) is less costly to investors than VIVAX (0.17). LBWCX is a more actively managed with annual turnover of: 75.00 vs. VIVAX (9.00). LBWCX has a lower initial minimum investment than VIVAX: LBWCX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. LBWCX (6.36). VIVAX return over 5 years is better than : 80.14 vs. LBWCX (39.40).
LBWCXVIVAXLBWCX / VIVAX
Total Expense Ratio1.900.171,118%
Annual Report Gross Expense Ratio1.910.171,124%
Fund Existence15 years33 years-
Gain YTD7.2696.209117%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets93.3M189B0%
Annual Yield % from dividends0.692.0634%
Returns for 1 year6.3612.0453%
Returns for 3 years18.3735.1652%
Returns for 5 years39.4080.1449%
Returns for 10 years16.46115.7414%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.